Securities Code: 300584 Securities Abbreviation: HEC Pharm Announcement No.: 2026-008
Nanjing HEC Pharm Co., Ltd. Announcement on Re-appointment of 2026 Audit Firm
The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or material omissions.
Nanjing HEC Pharm Co., Ltd. (hereinafter referred to as the "Company") held the fourth meeting of the Fifth Board of Directors on April 24, 2026, and reviewed and approved the "Proposal on Re-appointing the 2026 Audit Firm." It was agreed to re-appoint Tianheng Certified Public Accountants (Special General Partnership) (hereinafter referred to as "Tianheng") as the Company's 2026 audit firm, and submit it to the Company's 2025 Shareholders' Meeting for review. The relevant matters are hereby announced as follows:
I. Information on the Proposed Re-appointment of Accounting Firm
(I) Firm Information
-
Basic Information Name: Tianheng Certified Public Accountants (Special General Partnership) Firm Type: Special General Partnership Date of Establishment: November 4, 2013 Unified Social Credit Code: 913200000831585821 Registered Address: Room 1907, No. 106 Jiangdong Middle Road, Jianye District, Nanjing City, Jiangsu Province Managing Partner: Guo Ao
-
Personnel Information Number of Partners at the end of 2025: 85 Number of Certified Public Accountants at the end of 2025: 338 Number of Certified Public Accountants who signed securities audit reports at the end of 2025: 210
-
Business Information Total audited revenue in 2025: 49,572.28 million yuan Audit business revenue in 2025: 43,980.19 million yuan Securities business revenue in 2025: 15,967.65 million yuan